IgA nephropathy is a type of kidney disease that is typically treated with various medicines and lifestyle changes. Learn more about IgA nephropathy treatment here.

DENVER, Jan. 14, 2026 /PRNewswire/ -- Slumber, a rapidly emerging leader in sleep wellness, today announced the launch of Night Lytes (TM), a magnesium-based sleep powder formulated to enhance ...

Sensorineural hearing loss (SNHL) is a highly prevalent sensory disorder globally, affecting over 1.5 billion people, with a ...

Scientists have found that adding a missing phospholipid back into the bloodstream might help improve blood flow and reduce ...

COVID-19-associated thrombotic microangiopathy has emerged as a severe complication that exacerbates morbidity and mortality in critical cases. Thrombotic microangiopathy, characterized by ...

Novo Nordisk is paying $240 million for global rights to a Phase 3-ready drug from Omeros that could rival immune disorder medications currently available from companies such as AstraZeneca, Novartis, ...

FDA approval enables Complement Therapeutics to start the Opti-GAIN phase 1/2 trial for CTx001 in GA secondary to AMD. CTx001 is an AAV-based gene therapy delivering a truncated Complement Receptor 1 ...

Newcastle researchers have revealed the first treatment to target the underlying cause of a rare kidney condition called "C3G" and prevent the disease progressing. Publishing in The Lancet, the ...

Page parent Adam Duggins talks about the fresh coat of paint on the entrance and outside at the school in Greensboro on Sept. 10. Page's courtyard has been cleared of overgrowth. Light now shines in ...